Your browser doesn't support javascript.
loading
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.
Schoonderwoerd, Mark J A; Koops, Maaike F M; Angela, Ricardo A; Koolmoes, Bryan; Toitou, Melpomeni; Paauwe, Madelon; Barnhoorn, Marieke C; Liu, Yingmiao; Sier, Cornelis F M; Hardwick, James C H; Nixon, Andrew B; Theuer, Charles P; Fransen, Marieke F; Hawinkels, Lukas J A C.
Afiliação
  • Schoonderwoerd MJA; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Koops MFM; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Angela RA; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Koolmoes B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Toitou M; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Paauwe M; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Barnhoorn MC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Liu Y; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Sier CFM; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Hardwick JCH; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Nixon AB; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Theuer CP; Tracon Pharmaceuticals, San Diego, California.
  • Fransen MF; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
  • Hawinkels LJAC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. L.J.A.C.Hawinkels@lumc.nl.
Clin Cancer Res ; 26(14): 3831-3842, 2020 07 15.
Article em En | MEDLINE | ID: mdl-32332012

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos T Reguladores / Endoglina / Inibidores de Checkpoint Imunológico / Anticorpos Monoclonais / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos T Reguladores / Endoglina / Inibidores de Checkpoint Imunológico / Anticorpos Monoclonais / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article